PMA supplement
P100042 S034: Aptima HPV Assay
FDA PMA supplement · Normal 180 Day Track · Gen-Probe Incorporated
Key facts
| Original PMA | P100042 |
|---|---|
| Supplement number | S034 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Labeling Change - Indications/instructions/shelf life/tradename |
| Trade name | Aptima HPV Assay |
| Generic name | Kit, rna detection, human papillomavirus |
| Applicant | Gen-Probe Incorporated |
| Product code | OYB |
| Received date | Mar 28, 2022 |
| Decision date | Jun 2, 2023 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: